Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, Aurobindo Pharma Limited, has announced that the company has acquired a US FDA compliant cGMP (current good manufacturing practices) facility in Dayton, New Jersey. | |
| The facility is spread over 20 acres of freehold land and is located in Princeton Life Sciences Corridor in the state of New Jersey. |
| |
| The campus comprises one lakh square feet of fully integrated R&D, formulation manufacturing and distribution facilities with potential for future expansion. This facility will serve as Aurobindo's US headquarters, a press release said. |
| |
| PV Ramaprasad Reddy, chairman of Aurobindo, said that this purchase reinforced Aurobindo's commitment to serve the US market in an effective manner. |
| |
|
| |
